1
Participants
Start Date
September 30, 2011
Primary Completion Date
September 30, 2014
Study Completion Date
September 30, 2014
Data collection
Data collected when only the lyophilised formulation of Rotarix was in use (which is considered as baseline) will be specifically compared to data collected post the introduction of the liquid formulation. The results will also be compared to available vaccine coverage data for those rotavirus vaccines being used in Belgium.
GSK Investigational Site, Jette
GSK Investigational Site, Antwerp
GSK Investigational Site, Bonheiden
GSK Investigational Site, Hasselt
GSK Investigational Site, Yvoir
GSK Investigational Site, Charleroi
GSK Investigational Site, Ieper
GSK Investigational Site, Ghent
Lead Sponsor
GlaxoSmithKline
INDUSTRY